logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Erlie Jiang

Institute of Hematology
H指数:2
被引数:29

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

更正：费城染色体阳性急性淋巴细胞白血病合并附加细胞遗传学异常的移植结局：欧洲血液与骨髓移植学会急性白血病工作组的研究

Bone Marrow Transplantation
IF5.2
2026-08-310
OAAI
Arnon Nagler; Jordi Esteve; Jacques-Emmanuel Galimard; Depei Wu; Erlie Jiang; Nathalie Dhedin; Anne Sirvent; Jan Vydra; Jakob Passweg; Bruno Lioure; Jaime Sanz; Jurjen Versluis; Yajing Xu; Cristina Castilla-Llorente; Rodrigo Martino Bufarull; Victoria Potter; Nour Ben Abdeljelil; Eolia Brissot; Ali Bazarbachi; Bipin Savani; Sebastian Giebel; Mohamad Mohty; Fabio Ciceri
Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis

异基因造血干细胞移植后来特莫韦预防的最佳时机：来自真实世界时变暴露分析的研究启示

Bone Marrow Transplantation
IF5.2
2026-08-040
OA
Xueyao Li; Wenhao Wang; Ruixin Li; Jieya Luo; Xin Chen; Weihua Zhai; Rongli Zhang; Jialin Wei; Donglin Yang; Yi He; Aiming Pang; Sizhou Feng; Mingzhe Han; Yigeng Cao; Erlie Jiang
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

固定剂量奥佐米星（INO）联合长春新碱和泼尼松（VP）方案作为新诊断B细胞急性淋巴细胞白血病（B-ALL）的诱导治疗：一项多中心、开放标签、单臂、前瞻性临床研究

Blood Cancer Journal
IF11.6
2026-07-280
OA
Lei Ju; Sifeng Gao; JiLei Zhang; Yuyu Liu; Qiang Song; Lin Dong; Yan Guo; Xuemei Qin; Jie Zou; Chenglu Yuan; Yan Shi; Dexiao Kong; Kaifeng Wang; Qiang Li; Donglin Yang; Qingliang Teng; Erlie Jiang; Jun Peng; Guanchen Bai
EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT

EASIX和sC5b-9用于异基因造血干细胞移植后高危发生TA-TMA的成人早期识别

Bone Marrow Transplantation
IF5.2
2026-07-240
PRE
Wenwen Guo; Shulian Chen; Xiaoyu Zhang; Mingyue Xu; Xianjing Zhang; Jiali Wang; Yawei Zheng; Yuyan Shen; Qingzhen Liu; Xiaofei Ni; Mengnan Lv; Tingting Zhang; Yuanyuan Shi; Fengjiao Wang; Xiaoli Zhao; Jialin Wei; Rongli Zhang; Xin Chen; Yigeng Cao; Yong Li; Yueyi Mu; Aiming Pang; Mingzhe Han; Guoqing Zhu; Wenbin Cao; Erlie Jiang
Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities

携带附加细胞遗传学异常的费城染色体阳性急性淋巴细胞白血病的移植结果

Bone Marrow Transplantation
IF5.2
2026-07-130
OAAI
Arnon Nagler; Jordi Esteve; Jacques-Emmanuel Galimard; Depei Wu; Erlie Jiang; Nathalie Dhedin; Anne Sirvent; Jan Vydra; Jakob Passweg; Bruno Lioure; Jaime Sanz; Jurjen Versluis; Yajing Xu; Cristina Castilla-Llorente; Rodrigo Martino Bufarull; Victoria Potter; Nour Ben Abdeljelil; Eolia Brissot; Ali Bazarbachi; Bipin Savani; Sebastian Giebel; Mohamad Mohty; Fabio Ciceri
Optimizing treatment selection and timing of allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia with concurrent feline McDonough sarcoma (FMS)-like tyrosine kinase 3 internal tandem duplication, nucleophosmin 1 and deoxyribonucleic acid (DNA) methyltransferase 3 alpha mutations

优化伴有猫McDonough肉瘤(FMS)-样酪氨酸激酶3内部串联重复、核磷蛋白1和脱氧核糖核酸(DNA)甲基转移酶3α突变的急性髓系白血病的异基因造血干细胞移植治疗选择和时间

British Journal of Haematology
IF3.8
2026-06-020
PRE
Ruixin Li; Yiyi Yao; Donglin Yang; Liping Mao; Yinjun Lou; Yi He; Haitao Meng; Wenjuan Yu; Aiming Pang; Sizhou Feng; Hongyan Tong; Mingzhe Han; Jie Jin; Meiwen Tang; Erlie Jiang; Huafeng Wang
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AML

CBFB::MYH11 MRD在第二次化疗周期后的检测：在低危急性髓系白血病异基因移植中的指导作用

Bone Marrow Transplantation
IF5.2
2026-05-140
PRE
Mingyang Wang; Guangji Zhang; Wenwen Guo; Haixiao Zhang; Jiaxin Cao; Jieya Luo; Miao Yang; Yigeng Cao; Fengjiao Wang; Rongli Zhang; Xin Chen; Weihua Zhai; Qiaoling Ma; Jialin Wei; Donglin Yang; Yi He; Aiming Pang; Sizhou Feng; Mingzhe Han; Yingchang Mi; Jianxiang Wang; Hui Wei; Erlie Jiang
Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in patients with aplastic anemia undergoing PBSC-only allogeneic stem cell transplantation: a prospective phase II study

鲁索利替尼在预防再生障碍性贫血患者进行纯外周血干细胞异基因干细胞移植后发生移植物抗宿主病中的有效性和安全性：一项前瞻性II期研究

Experimental Hematology & Oncology
IF13.5
2026-03-080
OAAI
Xiaoyu Zhang; Lulu Pan; Yanhong Zhao; Runzhi Ma; Lining Zhang; Ying Zhang; Gang Li; Weihua Zhai; Qiaoling Ma; Aiming Pang; Donglin Yang; Sizhou Feng; Ping Zhang; Yi He; Guoyou Qin; Erlie Jiang; Mingzhe Han
Who is at risk? Clinical features and a predictive model for 30-day mortality in hematologic patients with enterococcal bloodstream infection

哪些患者处于风险之中？肠球菌血流感染血液病患者的临床特征及30天死亡率的预测模型

Frontiers in Cellular and Infection Microbiology
IF4.8
2026-03-040
OA
NY Nuobing Yang; SZ Sisi Zhen; TZ Tingting Zhang; YF Yuping Fan; QL Qingsong Lin; YM Yingchang Mi; YZ Yizhou Zheng; LQ Lugui Qiu; FZ Fengkui Zhang; EJ Erlie Jiang; MH Mingzhe Han; ZX Zhijian Xiao; JW Jianxiang Wang; SF Sizhou Feng; XC Xin Chen
Impact of prior solid tumor on outcomes of hematopoietic stem cell transplantation for hematologic malignancies: a propensity score-matched study

既往实体瘤对造血干细胞移植治疗恶性血液病预后的影响: 倾向评分匹配研究

Frontiers in Immunology
IF5.9
2026-02-050
OAAI
Jieya Luo†; Mingyang Wang†; Yunxia Zhou; Wenhao Wang; Wenbin Cao; Rongli Zhang; Xin Chen; Qiaoling Ma; Jialin Wei; Weihua Zhai; Yi He; Donglin Yang; Aiming Pang; Sizhou Feng; Mingzhe Han; Erlie Jiang
Incidence and risk factors for graft failure after allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

异基因造血干细胞移植后骨髓纤维化患者的移植物失败发生率和危险因素

BONE MARROW TRANSPLANTATION
IF5.2
2025-11-010
PRE
Sun, Yuqian; Zhu, Jun; Chen, Jia; Jiang, Erlie; Tang, Borui; Chen, Xinchuan; Zhao, Yanmin; Shi, Wei; Zhang, Xi; Zhou, Fang; Zhao, Mingfeng; Yan, Jinsong; Tan, Yehui; Xu, Shuangnian; Bai, Guanchen; Cao, Weijie; Cao, Yang; Fei, Xinhong; Zhou, Jian; Wang, Sanbin; Zhao, Peng; Miao, Kourong; Lu, Ying; Ding, Li; Yan, Zhiling; Dou, Liping; Lan, Mei; Wang, Shunqing; Wang, Zhiguo; Yi, Hai; Yuan, Hailong; Fang, Xiaosheng; Zhang, Hao; Huang, Xiaojun
Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants
Nature Communications
IF15.7
2025-09-250
OAAI
Junren Chen; Yigeng Cao; Yahui Feng; Saibing Qi; Donglin Yang; Yu Hu; Aiming Pang; Qiujin Shen; Jieya Luo; Xiaowen Gong; Rongli Zhang; Xiaolin Zhai; Xueqian Li; Wen Yan; Xianjing Zhang; Mengyun Chen; Mingming Niu; Jialin Wei; Chen Liang; Weihua Zhai; Ningning Zhao; Xueou Liu; Sichang Liu; Wangsong Zhai; Ruixin Li; Xianfeng Shao; Dong Zhang; Mingyang Wang; Pan Pan; Mingyue Xu; Wei Zhang; Yunqiang Xu; Xiaofan Zhu; Ye Guo; Hong Wang; Zhen Song; Robert Peter Gale; Mingzhe Han; Sizhou Feng; Erlie Jiang
Efficacy and Safety of the Third-Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation

第三代酪氨酸激酶抑制剂Olverembatinib与Inotuzumab Ozogamicin联合治疗成人费城染色体阳性急性淋巴细胞白血病患者的疗效与安全性：适用于难治/复发疾病或持续性微小残留病，作为桥接造血干细胞移植的方案。

American Journal of Hematology
IF9.9
2025-08-060
OAAI
Xiaoyu Zhang; Yigeng Cao; Jialin Wei; Weihua Zhai; Qiaoling Ma; Chen Liang; Xin Chen; Wenbin Cao; Donglin Yang; Aiming Pang; Yi He; Sizhou Feng; Mingzhe Han; Rongli Zhang; Erlie Jiang

研究方向

暂未获取到该数据
A
Aiming Pang
H 指数:17论文数:208被引数:1,214
Y
Yigeng Cao
H 指数:8论文数:73被引数:241
D
Donglin Yang
H 指数:19论文数:178被引数:2,092
Y
Yi He
H 指数:8论文数:59被引数:570
W
Weihua Zhai
H 指数:14论文数:150被引数:717
R
Rongli Zhang
H 指数:3论文数:21被引数:31
J
Jialin Wei
H 指数:13论文数:185被引数:786
Q
Qiaoling Ma
H 指数:13论文数:158被引数:625
M
Mingyang Wang
H 指数:32论文数:274被引数:3,948
W
Wenwen Guo
H 指数:6论文数:21被引数:144